A Glimpse Into The Expert Outlook On Becton Dickinson Through 4 Analysts
Portfolio Pulse from Benzinga Insights
Analysts have varied opinions on Becton Dickinson (NYSE:BDX), with recent ratings showing a mix of bullish and somewhat bullish sentiments. The average 12-month price target has increased to $270.0, with a high of $280.00 and a low of $255.00. Analysts have adjusted their ratings and price targets based on market conditions and company performance. Becton Dickinson is a major player in the medical surgical products industry, with strong revenue growth and net margins but challenges in ROE, ROA, and debt management.
October 01, 2024 | 3:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Becton Dickinson (BDX) has received mixed analyst ratings, with a new average price target of $270.0. The company shows strong revenue growth and net margins but faces challenges in ROE, ROA, and debt management.
The mixed analyst ratings and slight increase in the average price target suggest a neutral short-term impact on BDX's stock price. While the company shows strong revenue growth and net margins, challenges in ROE, ROA, and debt management may offset positive sentiments.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100